US · UPC
Universe Pharmaceuticals Inc.
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Ji'An 343100
- Website
- universe-pharmacy.com
Price · as of 2025-09-30
$3.21
Market cap 1.53M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $156,003.27 | +4,859,814.95% |
| Intrinsic Value(DCF) | $6,595.94 | +205,381% |
| Graham-Dodd Method(GD) | $10,859.47 | +338,201.25% |
| Graham Formula(GF) | $14,037.48 | +437,204.77% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | $0.00 | $31,081.92 | |||
| 2020 | $10,045.26 | $1,115.49 | |||
| 2021 | $6,408.00 | $320,358.97 | $825,395.34 | $21,914.67 | $132,882.66 |
| 2022 | $5,760.00 | $86,551.20 | $2,627.34 | $465.89 | $11,146.05 |
| 2023 | $852.00 | $389,895.86 | $2,811.79 | $1,471.79 | $11,047.72 |
| 2024 | $135.60 | $1,994,154.09 | $4,035.40 | $307.13 | $27,885.69 |
| 2025 | $4.18 | $156,003.27 | $10,971.61 | $10,859.47 | $14,037.48 |
AI valuation
Our deep-learning model estimates Universe Pharmaceuticals Inc.'s (UPC) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $156,003.27
- Current price
- $3.21
- AI upside
- +4,859,814.95%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$6,595.94
+205,381% upside
Graham-Dodd
$10,859.47
+338,201.25% upside
Graham Formula
$14,037.48
+437,204.77% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| UPC | Universe Pharmaceuticals … | $3.21 | 1.53M | +4,859,815% | +205,381% | +338,201% | +437,205% | 0.00 | 0.00 | 0.00 | 8.32 | — | 0.00 | 35.28% | -16.33% | -20.56% | -7.23% | -10.45% | -5.35% | 0.16 | -12.57 | 4.07 | 3.55 | 8.33 | -2649.00% | -2244.00% | -4529.00% | -37140.54% | -0.38 | -19.36% | 0.00% | 0.00% | 19477.17% | 8.34 | 4.50 | -1.36 | 0.54 |
| BCTXZ | BriaCell Therapeutics Cor… | $0.17 | 315.72K | — | — | — | — | — | — | — | — | — | — | 0.00% | — | — | -237.76% | -2090.29% | -192.98% | 0.00 | -735.71 | 5.01 | 4.69 | 0.29 | 191519.00% | — | 1459.00% | — | -7.08 | -1560.53% | — | 0.00% | — | — | — | — | — |
| BJDX | Bluejay Diagnostics, Inc. | $2.05 | 929.76K | — | — | — | — | -0.10 | 0.13 | — | 0.49 | -0.17 | 0.13 | 0.00% | — | — | -178.98% | -533.23% | -133.92% | 0.04 | -8.71 | 6.05 | 5.33 | 0.61 | 5724.00% | — | -989.00% | -1057.58% | -9.65 | -604.40% | 0.00% | 0.00% | 289.45% | 0.46 | 0.41 | — | -9.61 |
| ELAB | PMGC Holdings Inc. | $1.19 | 126.21K | +401,467% | +24,631% | — | — | -0.06 | 0.06 | 0.16 | 1.12 | — | 0.10 | 72.84% | -75.65% | -253.14% | -119.12% | -110.26% | -88.07% | 0.00 | -2.54 | 3.36 | 2.22 | 1.25 | -8600.00% | 4407.00% | 2032.00% | -1366.73% | -3.05 | -324.66% | 0.00% | 0.00% | 215.87% | 1.92 | 0.65 | -1.45 | -1.81 |
| MLEC | Moolec Science S.A. | $13.30 | 9.66M | +7,515% | +24,189,467% | — | — | -0.07 | -0.12 | 0.02 | -3.56 | 0.00 | -0.05 | 34.17% | -3.14% | -33.41% | 376.84% | -11.15% | -93.08% | -3.74 | -0.25 | 0.13 | 0.12 | -3.57 | 897895.00% | 583074.00% | 21733.00% | -393.07% | -0.10 | -32.03% | 0.00% | 0.00% | 12.10% | -23.43 | -8.16 | 0.74 | -0.48 |
| NCEL | NewcelX Ltd. | $2.90 | 1.31M | — | — | — | — | -0.65 | 0.91 | — | 0.11 | -0.09 | 0.91 | 0.00% | — | — | 53.34% | 104.83% | -97.10% | 0.00 | -29.20 | 2.69 | 2.50 | 0.46 | 72188.00% | — | -5589.00% | -333.71% | -5.16 | 102.24% | 0.00% | 0.00% | 187.60% | 0.09 | 0.09 | — | -51.45 |
| PRFX | PRF Technologies Ltd. | $2.97 | 239.18K | — | — | — | — | -0.02 | 0.15 | — | 0.27 | — | 0.15 | 0.00% | — | — | -321.92% | 948.79% | -201.84% | 0.02 | -1048.07 | 1.81 | 1.79 | 0.29 | -8123.00% | — | 8891.00% | -4551.60% | -5.17 | 816.94% | 0.00% | 0.00% | 0.00% | 0.27 | 0.31 | — | -27.58 |
| SHPH | Shuttle Pharmaceuticals H… | $1.00 | 1.07M | — | — | — | — | -13.69 | 176.53 | — | -16.00 | -0.01 | 176.53 | 0.00% | — | — | -383.84% | 4303.31% | -216.24% | 1.65 | -5.66 | 1.44 | 1.25 | 0.10 | 21593171.00% | — | 3084.00% | -5.85% | -4.78 | 4097.02% | 0.00% | 0.00% | 0.00% | -16.17 | -16.98 | — | 12.67 |
| TIVC | Tivic Health Systems, Inc… | $0.82 | 889.68K | +3,622% | +81% | — | -43% | -189.04 | 421.70 | 1370.53 | -200.98 | — | 421.70 | 0.26% | -725.77% | -725.00% | -184.96% | -1041.58% | -142.01% | 0.00 | — | 9.70 | 7.61 | 0.38 | -8887.00% | -3367.00% | -3365.00% | -0.54% | -21.05 | -1053.36% | 0.00% | 0.00% | 0.00% | -188.49 | -186.38 | 1367.97 | 2331.04 |
About Universe Pharmaceuticals Inc.
Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
- CEO
- Gang Lai
- Employees
- 225
- Beta
- 1.52
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($6,595.94 ÷ $3.21) − 1 = +205,381% (DCF, example).